Company Profile
Public information reviewedAcumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease.
USNASDAQ: ABOS
Follow
More
- Evidence records
- 2
- Published leadership records
- 2
- Record reviewed
- Sep 26, 2026

